Investigators conducted a randomized clinical trial to assess the safety and efficacy of the investigational stimulant AR19 for the treatment of symptoms of attention-deficit/hyperactivity disorder in adults.
Investigators sought to identify characteristics associated with length of hospital stay in individuals undergoing electroconvulsive therapy for bipolar disorder.
Research was conducted to assess the impact of initiation of treatment with second-generation antipsychotics and treatment interruptions on weight gain in patients with schizophrenia and bipolar 1 disorder.
Investigators conducted a comprehensive literature search to identify key characteristics that best differentiate between bipolar I disorder and major depressive disorder.
Clinical trials were conducted to assess the effect brexanolone and zuranolone, neuroactive steroids that are positive allosteric modulators of the gamma-aminobutyric acid receptor, on depression in postpartum women.
